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Abstract  Hereditary  hemorrhagic  telangiectasia  (HHT)  or  Rendu-Osler-Weber  disease  is  an
autosomic  dominant  disorder,  which  is  characterized  by  the  development  of  multiple  arteriove-
nous malformations  in  either  the  skin,  mucous  membranes,  and/or  visceral  organs.  Pulmonary
arteriovenous  malformations  (PAVMs)  may  either  rupture,  and  lead  to  life-threatening  hemopt-
ysis/hemothorax  or  be  responsible  for  a  right-to-left  shunting  leading  to  paradoxical  embolism,
causing stroke  or  cerebral  abscess.  PAVMs  patients  should  systematically  be  screened  as  the
spontaneous  complication  rate  is  high,  by  reaching  almost  50%.  Neurological  complications  rate
is considerably  higher  in  patients  presenting  with  diffuse  pulmonary  involvement.  PAVM  diagno-
sis is  mainly  based  upon  transthoracic  contrast  echocardiography  and  CT  scanner  examination.
The latter  also  allows  the  planiﬁcation  of  treatments  to  adopt,  which  consists  of  percutaneous
embolization,  having  replaced  surgery  in  most  of  the  cases.  The  anchor  technique  consists  of
percutaneous  coil  embolization  of  the  afferent  pulmonary  arteries  of  the  PAVM,  by  ﬁrstly  pla-
cing a  coil  into  a  small  afferent  arterial  branch  closely  upstream  the  PAVM.  Enhanced  contrast
CT scanner  is  the  key  follow-up  examination  that  depicts  the  PAVM  enlargement,  indicating
the various  mechanisms  of  PAVM  reperfusion.  When  performed  by  experienced  operators  as
the prime  treatment,  percutane
therapy  in  the  great  majority  of
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a  single  aneurismal  sac  directly  communicating  with  the  left
circulation.  Finally,  the  third  portion  of  the  PAVM  consists  of
one  or  more  draining  veins  whose  diameters  are  larger  than
Figure 1. Simple pulmonary arteriovenous malformation (PAVM)
located at the lower left posterior basal segment. Positive transtho-
racic echocardiography (grade 3) in a hereditary hemorrhagic
telangiectasia (HHT) family 35-years-old patient. Thirty degrees
left anterior oblique volume rendering CT scanner shows a simple36  
ntroduction
ereditary  hemorrhagic  telangiectasia  (HHT)  or  Rendu-
sler-Weber  disease  is  an  autosomic  dominant  disorder,
hich  occurs  in  approximately  10  to  20  individuals  per
00,000,  characterized  by  the  development  of  multiple  arte-
iovenous  malformations  of  the  skin,  mucous  membranes,
nd  visceral  organs  including  cerebral,  spinal,  hepatic,  pan-
reatic  and  pulmonary  arteriovenous  malformations  (PAVMs)
1—6].
Two  main  types  of  HHT  disease  represent  80%  of  the  cases
nd  are  due  to  the  mutations  in  the  ENG  gene  (encoding  for
ndoglin)  and  activin  type-II-like  receptor  kinase  1  (ACVRL1)
ene  (encoding  for  the  activin  receptor  like  kinase  (ALK1)),
ausing  respectively  HHT  type  1  and  HHT  type  2  diseases.
he  ENG  and  ACVRL1  genes  code  for  proteins  of  the  TGF
eta  receptor,  which  is  involved  in  the  proper  blood  vessel
evelopment  [7].  The  mutation  of  the  SMAD4  gene,  which
s  involved  in  TGF  beta  signal  transduction,  may  also  cause
HT  disease,  in  association  with  juvenile  polyposis  [8].
HHT  should  be  precisely  clinically  diagnosed  on  the  basis
f  the  Curac¸ao criteria.  Three  criteria  are  thus  needed
mong  the  following:
multiple  mucocutaneous  telangiectases;
spontaneous  and  recurrent  epistaxis;
visceral  involvement;
a  family  ﬁrst  degree  history  of  HHT  [9].
Penetrance  is  age-related  and  is  almost  complete  by  the
ge  of  40-years-old  [1].  Mild  to  moderate  epistaxis  is  the
ost  common  symptom  of  HHT.  Cerebral  vascular  malfor-
ations  have  been  reported  in  3.7%  out  of  321  HHT  patients,
nd  included  ten  cases  of  AVM,  one  dural  arteriovenous
stula  and  one  cavernomatous  malformation  [10]. A  sub-
tantial  proportion  of  patients  presenting  with  HHT  disease
ay  be  affected  by  liver  involvement,  which  can  cause
bdominal  pain,  abnormal  serum  liver  function  tests  results,
seudocirrhosis,  biliary  necrosis  and  even  high  cardiac  out-
ut  failure  [11].  Pancreatic  involvement  has  been  reported
n  31%  of  the  cases,  mainly  in  association  with  ALK1  mutation
atients  [12].
Pulmonary  arteriovenous  malformations  represent  the
ost  common  pattern  of  the  pulmonary  involvement  to  be
ncountered  in  HHT  patients.  ALK1-type  related  pulmonary
rterial  hypertension  may  also  be  observed  [13].  Paradoxical
mbolism  due  to  de  novo  in  situ  cruoric  thrombus  originating
rom  the  PAVM  (tight  stenosis  related  venous  stasis,  turbu-
ent  ﬂow  within  a  large  sac)  or  septic,  cruoric  thrombus
r  air  embole  originating  upstream  the  PAVMs  is  one  of  the
ain  causes  of  morbidity,  responsible  for  stroke  and  cere-
ral  abscess  events  [14].  PAVMs  may  also  rupture,  causing
ife  threatening  hemoptysis  or  hemothorax  [15].
This  overview  article  aims:
ﬁrstly,  to  describe  the  progressive  development  and  radio-
anatomical  characteristics  of  PAVMs,  and  their  potential
complications;
secondly,  to  report  the  technical  aspects  and  outcomes
of  percutaneous  embolization  to  prevent  and  treat  PAVMs
related  complications;
thirdly,  to  show  CT  scanner/angiographic  —  pathological
correlations.
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ulmonary arteriovenous malformations
ulmonary arteriovenous malformation
natomy and classiﬁcation
ulmonary  arteriovenous  malformations  are  abnormal  direct
ommunications  between  pulmonary  arteries  and  pulmonary
eins  without  interposition  of  a  capillary  bed.  Approximately
0  to  90%  of  patients  presenting  with  PAVMs  eventually
resent  HHT,  whereas  the  remaining  are  sporadic  cases
16,14].  Conversely,  15  to  35%  of  HHT  patients  will  present
AVMs  [16,14].  The  PAVMs  have  a  natural  tendency  to
ncrease  in  size  over  time.  Various  factors  including  puberty,
regnancy  and  also  pulmonary  arterial  hypertension  (PAH)
ay  explain  this  phenomenon.  Contrary  to  sporadic  forms,
HT-PAVMs  are  often  multiple,  bilateral  and  preferentially
ocated  at  the  pulmonary  bases  [14,17].
The  PAVM  consists  of  three  different  anatomical  com-
onents:  one  or  more  than  one  feeding  artery(ies),  an
neurismal  sac  and  one  or  more  draining  vein  (Fig.  1).  The
eeding  artery  may  be  long,  (Fig.  1)  or  very  short,  thus  mak-
ng  percutaneous  embolization  more  challenging  (Fig.  2).
he  aneurismal  part  of  the  PAVM  may  be  either  a  sac  or  a  ser-
iginous  network  (Figs.  1,  3,  4).  Distinction  between  these
wo  different  patterns  is  crucial  to  plan  the  appropriate  per-
utaneous  treatment  as  the  risk  of  accidental  embolization
evice  migration  to  the  left  heart  is  higher  when  consideringAVM. A single postero basal afferent feeding artery (arrow) and
n aneurismal sac (arrowhead) are shown. The aneurismal sac is
ocated in the subpleural space. Note the draining vein diameter
hat is larger than that of the artery (large arrow).
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Figure 2. Short solitary afferent artery feeding a simple large pulmonary arteriovenous malformation (PAVM) in the left lung in a 79-
years-old woman presenting with multiple discrete PAVMs. Selective angiogram of the left latero basal artery in a 45 degrees right anterior
oblique view before (a) and during embolization (b) discloses a very short subsegmental anterior artery (arrow) feeding the large aneurismal
 insid
•
•
•sac (arrowhead). The anchor technique permitted the coil blockage
aneurismal sac (curved arrow).
the  afferent  feeding  artery  (Figs.  1  and  5).  A  simple  PAVM
(approximately  80%  of  the  cases)  is  characterized  by  one  or
more  afferent  feeding  arteries  originating  from  a  single  seg-
mental  pulmonary  artery  (Fig.  1),  while  a  complex  PAVM  has
multiple  afferent  feeding  arteries  originating  from  several
segmental  arteries  (Fig.  4)  [14,18].
PAVMs  development  comprises  three  main  steps  as  fol-
lows:
• a  ground  glass  nodule  corresponds  to  the  initial  enlarge-ment  of  the  postcapillary  venules  associated  with  an
inﬂammatory  cell  inﬁltrate;
Figure 3. Various patterns of aneurismal arterio venous connections. T
the posterior segment of the left upper lobe (a) shows a serpiginous netw
right anterior oblique angiogram of a latero basal segmental artery (b) 
risk of accidental distal device migration to the left circulation is higher 
a stenosis of a pulmonary arteriovenous malformation (PAVM) may repree the subsegmental branch (large arrow). Coils are shown into the
small  vessels  that  are  visible  within  the  ground  glass  nod-
ule  represent  vascular  branching  and  connection  between
the  precapillary  pulmonary  artery  and  the  postcapillary
venules,  throughout  the  capillary  bed;
enlargement  of  the  draining  vein;
the  deﬁnitive  PAVM  corresponds  to  a  feeding  pulmonary
artery,  an  aneurysmal  sac  and  an  enlarged  draining  vein
with  concomitant  disappearance  of  the  ground  glass  pat-
tern  (Fig.  6) [19].  At  this  stage,  the  PAVM  will  evolve  for
its  own  account.  Rarely,  PAVMs  will  evolve  to  a  giant  form
(Fig.  7).
hirty degrees left anterior angiogram of a subsegmental branch of
ork channel (arrow) drained by two efferent veins. Thirty degrees
shows stenosis of the arteriovenous connection (large arrow). The
in case of a large straight channel aneurismal sac. The presence of
sent a local factor for spontaneous PAVM thrombosis.
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Figure 4. Complex pulmonary arteriovenous malformation
(PAVM) with afferent feeding arteries originating from different seg-
mental pulmonary arteries. 82-years-old hypoxemic female with a
persistent positive transthoracic echocardiography (grade 3) after
percutaneous closure of a patent foramen ovale. Thirty degrees left
anterior oblique volume rendering CT scanner shows a complex PAVM
fed by two afferent arteries: a small lingular artery (arrow) and a
large antero basal artery (curved arrow). The CT scanner also shows
a serpiginous aneurismal sac (arrowhead) and an enlarged draining
vein (large arrow).
Figure 5. Simple pulmonary arteriovenous malformation (PAVM)
presenting with an enlarged draining vein. Twenty degrees right
anterior oblique angiogram of a left anterior basal artery shows
a simple PAVM presenting a fusiform aneurism of the draining vein
(arrow). The pattern of draining veins is presumably related to the
high ﬂow output within the PAVM and/or to the pulmonary hyperten-
sion. Moreover, angiogram displays dynamic variations of the ﬁlling
of draining veins according to the cardiac cycle. In case of a high
output cardiac failure with pulmonary venous hypertension, a ret-
rograde ﬁlling of a successfully embolized PAVM can be observed
(Fig. 21).
Figure 6. Spectrum of pulmonary arteriovenous malformation
(PAVM) disease development on CT scanner. CT scanner ﬁrst step
shows isolated nodular or ill deﬁned ground-glass attenuation. It
corresponds to the initial venous telangiectasic stage. This initial
telangiectasic stage is followed by the pulmonary venous enlarge-
ment, which correspond to microscopic arteriovenous connections.
In next stages, vascular branching is depicted on CT: the feeding
artery lies within the ground-glass nodule, while draining veins are
visible in the periphery of the nodule. Finally the development of
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[ true PAVM occurs with an aneurismal sac and concomitant disap-
earance of the nodule or ground glass densities.
ulmonary arteriovenous malformation
epartition
he  repartition  type  of  the  PAVM  in  HHT  patient  lungs  may  be
ither  discrete  or  diffuse  (5—7%).  Diffuse  pattern  of  PAVMs
s  variably  deﬁned  as  PAVMs  involving  every  segmental  or
very  subsegmental  artery  of  at  least  one  lobe  [20].  Dif-
use  involvement  has  also  minimally  been  deﬁned  as  one
egment  diffusely  involved  [21].  A  more  clinically  relevant
lassiﬁcation  has  been  proposed,  as  follows:  patients  pre-
enting  with  involvement  of  every  subsegmental  artery  of  at
east  one  lobe  (diffuse  subsegmental  form)  (Fig.  8),  patients
resenting  with  involvement  of  every  segmental  artery  of
t  least  one  lobe  (diffuse  segmental  form)  (Fig.  9),  and
atients  presenting  with  a  combination  of  subsegmental
nd  segmental  involvement  of  at  least  one  lobe  (diffuse
ixed  segmental/subsegmental  form)  [22].  Symptoms  that
nclude  hypoxemia,  hemoptysis,  and  neurological  symptoms
re  more  frequently  correlated  to  diffuse  patterns  [20].
aradoxical  embolism  is  more  frequently  encountered  in  the
iffuse  subsegmental  form  [22].
pontaneous pulmonary arteriovenous
alformations  complications
AVMs  may  be  responsible  for  a  paradoxical  clot  embolism
ue  to  the  absence  of  the  capillary  ﬁlter  bed  interpo-
ition  between  the  arterial  and  venous  circulation.  As  a
atter  of  fact,  stroke  and  cerebral  abscess  events  are
ncontrolled  right-to-left  shunt  related  complications  due
o  clot/septic  thrombus  embolization  through  out  the  PAVM
14]. The  right-to-left  blood  shunting  may  cause  hypoxia
Diagnosis  and  treatment  of  pulmonary  arteriovenous  malformations  839
Figure 7. Incidental diagnosis of a giant sporadic pulmonary arteriovenous malformation (PAVM) on a chest X-ray in a 16-years-old male
patient presenting a right chest pain. Frontal chest x-ray (a) and coronal contrast-enhanced MIP CT scanner reformation (b) show a giant
simple PAVM in the middle lobe, a single afferent artery (arrow), feeding a giant aneurismal sac larger than left ventricle (arrowhead), and
a large single efferent draining vein (large arrow). Axial contrast-enhanced CT scanner (c) shows peripheral clots (arrows) and a parietal
calciﬁcation (arrowhead). PAVM transparietal ultrasonography (d) conﬁrms the presence of parietal thrombus, possible source of paradoxical
embolism (arrow). Factors that contribute to plan surgery rather than embolization were the age of the patient with a single PAVM, the
presence of pain suggesting a complication, the large volume and clot ﬁlled aneurismal sac. Before surgery, hemoglobin level was 22 g/dL.
Pulmonary artery pressures were 24 (systolic), 11 (diastolic) and 16 mmHg (mean). The pulmonary capillary wedge pressure was 12 mmHg.
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DThe cardiac output and cardiac index were 5.4L/min, and 2.8L/min
operative full recovery. Photograph (e) of the resected middle lob
organized (white) thrombi within the aneurismal sac.
and  subsequent  polycythemia  (Fig.  7)  [23].  Spontaneous
thrombosis  of  a  PAVM  is  rare  and  may  be  symptomatic  and
responsible  for  embolism  to  the  left  circulation  (Fig.  10).
The  thin-walled  PAVM  aneurismal  sac  may  also  rupture.
Most  of  the  PAVMs  have  a  subpleural  localisation  and  may
be  revealed  by  a  combination  of  potential  life  threat-
ening  hemoptysis/hemothorax  and  neurological  signs  due
to  cough  favoured  systemic  air  embolism  (when  rupture
occurs  into  lung  parenchyma,  alveolar  haemorrhage  triggers
patient’s  cough,  increased  intrathoracic  pressure  and  sub-
sequent  paradoxical  air  embolism  through  the  parietal  PAVM
tear)  (Figs.  11  and  12).  Ruptures  may  be  favoured  by  preg-
nancy  probably  due  to  the  increased  blood  volume  as  well  as
alterations  in  the  vascular  tone  related  to  changing  serum
estrogen  and  progesterone  concentrations  [15,24].
m
T
C, respectively. The patient underwent middle lobectomy, and post
wing the giant PAVM at gross examination, with fresh (dark) and
PAH  may  occur  and  be  favoured  by  both  pulmonary  arte-
ial  vasconstriction  secondary  to  PAVMs  induced  chronic
ypoxemia  and  high  blood  ﬂow  output  due  to  intrahepatic
hunts  (arterioportal,  portohepatic  and/or  arteriohepatic
hunts)  [25]. ALK1  and  more  rarely  endoglin  mutations
ay  also  be  a  proper  cause  of  heritable  PAH  [13,14,26].
lso,  PAH  may  contribute  to  the  PAVM  enlargement
3].
iagnosis of pulmonary arteriovenous
alformation
ransthoracic  Contrast  Echocardiography  (TTCE)  and  Chest
T  scanner  examination  are  the  two  main  tools  permitting
840  P.  Lacombe  et  al.
Figure 8. Subsegmental diffuse pulmonary arteriovenous malformation of the middle lobe in a 31-years-old female patient presenting with
a low PaO2 level (34 mm Hg). CT scanner (a) showing all peripheral subpl
connections (arrows). Selective angiogram of the left latero basal segme
arterio venous connections (arrows).
Figure 9. Axial MIP CT scanner shows diffuse segmental pul-
monary arteriovenous malformation (PAVM) of the middle lobe. All
the segmentar arteries of the middle lobe display arteriovenous
malformations (arrows). Multiple discrete PAVMs are shown within
the right lower lobe (arrowheads).
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Figure 10. Asymptomatic partial thrombosis of the pulmonary arteriov
scanner in a 34-years-old female paient without any clinical signs of syst
shows a thrombus within the aneurismal sac of a PAVM in the anterior se
planned for one month. Pre-embolization angiogram disclosed a tiny resid
successfully performed. Angiogram (b) showing an incidental clot within
the left inferior lobe (arrow). Immediate embolization was performed weural subsegmental arterial branches dysplaying tiny arteriovenous
nt (b), in a right anterior projection showing diffuse subsegmental
AVMs  screening  and  evaluation  in  patients  presenting  with
HT  [26]. Both  TTCE  and  CT  scanner  examinations  should
e  performed  carefully  to  prevent  intravenous  gazeous  or
eptic  injection  that  may  lead  to  iatrogenic  paradoxical
mbolism.  Isotopic  and  blood  oxygen  levels  right-to-left
hunt  measurements  are  insufﬁciently  sensitive  to  exclude
AVMs  diagnosis  [26,27].  Chest  radiograph  is  an  easy,  fast,
ow  radiation  exposure  examination  used  as  a  ﬁrst  line  PAVM
creening  test  although  its  sensitivity  is  low,  particularly
or  the  detection  of  small  diameter  PAVM.  PAVMs  appear  as
ounded  well  circumscribed  lesions  with  branching  afferent
eeding  and  dilated  efferent  draining  vessels  (Fig.  13)  [27].
lthough  contrast-enhanced  magnetic  resonance  angiogra-
hy  (MRA)  is  not  currently  performed  for  PAVMs  screening,
ecent  studies  have  concluded  that  MRA  was  a  contributive
djunct  to  pre-embolization  planning  [28—30]. The  main
dvantage  of  MRA  over  the  other  techniques  is  to  avoiding
onizing  radiation  exposure.
TTCE  is  a  rapid  simple  and  minimally  invasive  exam-
nation  used  as  an  initial  PAVMs  screening  examination
enous malformation (PAVM) aneurismal sac. Contrast-enhanced CT
emic paradoxical cruoric or septic embolism. Axial reformation (a)
gment of the right upper lobe (arrow). Anticoagulant therapy was
ual clot abutting the feeding artery (not shown). Embolization was
 the aneurismal sac of a simple PAVM of the laterobasal segment of
ithout any immediate or delayed complication.
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Figure 11. Acute hemothorax revealing a ruptured subpleural pulmonary arteriovenous malformation (PAVM). A 56-years-old female
patient presenting with acute hemothorax and systemic hypotension due to intra pleural rupture of a peripheral PAVM during transatlantic
air ﬂight travel. The diagnosis of hereditary hemorrhagic telangiectasia (HHT) was suspected on recurrent spontaneous epistaxis and multiple
cutaneous telangiectases. Sagittal (a) contrast-enhanced CT scanner reformation shows the PAVM herniation into the pleural space (arrow),
hematic pleural effusion (large arrow) and a large fresh clot adjacent to the PAVM (arrowhead). The diagnosis of HHT was conﬁrmed by
the presence of the pulmonary and hepatic involvement. Prior to embolization, pulmonary artery pressure level assessment indicated
severe pulmonary hypertension (systolic 92, diastolic 35, mean, 56 mmHg), secondary to a severe HHT hepatic involvement. Percutaneous
emergency embolization was successfully performed. Angiograms (b and c) show a tortuous afferent feeding artery and a tiny PAVM wall
d the
cizum
d
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irupture (arrow). Coils were successfully anchored into the artery an
unchanged after embolization. Indication for anti-angiogenic (Beva
[31].  After  intravenous  injection  of  agitated  saline  solution,
echoic  microbubbles  can  be  easily  depicted  in  the  left  car-
diac  cavities  after  two  to  ﬁve  cardiac  beats,  thus  suggesting
the  presence  of  a  right-to-left  pulmonary  shunt  (whereas
microbubbles  that  are  immediately  visible  after  injection
may  suggest  the  presence  of  an  intra  cardiac  shunt)  (Fig.  13).
Interestingly,  a  grading  of  positive  TTCE  results  has  been
established  according  to  the  number  of  microbubbles  that
could  be  detected  (Fig.  14)  [31,32].  The  reported  diagnos-
tic  sensitivity  of  TTCE  is  high  (up  to  97%)  and  the  negative
predictive  value  is  99%  in  published  series  where  chest  CT
scanner  was  used  as  the  gold  standard  for  PAVMs  diagnosis
[33].
s
t
s
c aneurismal sac (arrowhead). Pulmonary artery pressures remained
ab) treatment of the hepatic involvement of HHT was  discussed.
Indeed,  CT  scanner  is  considered  as  the  gold  standard
iagnosis  tool  as  it  provides  an  easy  patient  screening,  a
igh  anatomical  resolution,  a  precise  location  (multiple  dis-
rete  or  diffuse  form)  and  type  deﬁnition  (e.g.  simple  versus
omplex)  of  the  PAVM.  Furthermore,  this  tool  is  useful  for
ercutaneous  embolization  planiﬁcation  and  follow-up  [34].
As  a  matter  of  fact,  we  usually  perform  a contrast-
nhanced  thoraco  abdominal  CT  examination  at  our
nstitution.  This  allows  us  to  depict  the  PAVM  feeding  ves-
els  and  the  aneurismal  sac  lumen  that  can  be  spontaneously
hrombosed  before  treatment  (Fig.  10),  to  detect  the  PAVMs
ystemic  supply  (Fig.  15),  and  the  subphrenic  speciﬁc  vis-
eral  involvement  (liver  and/or  pancreatic  involvement)
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Figure 12. Spontaneous pulmonary rupture of a pulmonary arte-
riovenous malformation (PAVM). This 35-years-old man presented a
sudden cough immediately followed by hemoptysis and concomitant
transient right hemiparesis. PAVM parenchymal rupture (hemopty-
sis) of a PAVM and a systemic cerebral gas embolism (that may be
facilitated by cough) were suspected. Contrast-enhanced CT scan-
ner examination revealed alveolar hemorrhage related ground glass
attenuation (arrow) circumscribing the ﬁssured PAVM aneurismal
sac. Emergency embolization of the culprit PAVM was successfully
performed, as well as embolization of three other non complicated
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Figure 14. Transthoracic contrast echocardiography shows Grade
3 right-to-left shunt. Microbubbles ﬁll in the left atrium and
ventricle after three cardiac beats (arrow). A large pulmonary
arteriovenous malformation was suspected and conﬁrmed on CT
scanner.AVMs. The patient remains asymptomatic ten years after the initial
nset of symptoms.
11,12].  In  patients  presenting  without  PAVM,  identiﬁcation
f  liver/pancreatic  involvement  provides  the  third  visceral
iagnostic  item  and  subsequently  helps  to  early  clinical  diag-
osis  and  improved  management  of  HHT  disease.  A  steal
henomenon  might  be  encountered  on  both  angiographic
nd  CT  scanner  examination  due  to  the  PAVMs  high  blood
ow  output  (Fig.  16)  in  a  low-resistance  vascular  system,  and
igure 13. Pulmonary arteriovenous malformation (PAVM) depic-
ion by using MRA. Frontal SSFP (Fiesta) MRA in a 23-years-old
regnant woman presenting with dysraphism related hydronephro-
is and orthodeoxia syndrome. A single PAVM was fortuitously
etected within the lateral-basal segment (arrow) of the right lung.
ransthoracic echocardiography was positive. Low radiation dose CT
canner examination conﬁrmed the presence of a lateral-basal seg-
ent PAVM and other multiple discrete PAVMs. Embolization of two
AVMs in the right lower lobe was successfully performed without
mmediate complication. The child was born by caesarean section
 days later.
Figure 15. Initial systemic supply to a large pulmonary arteri-
ovenous malformation (PAVM) of the middle lobe. Frontal MIP CT
scanner MIP shows off a huge PAVM in the middle lobe (arrowhead).
Right multiple enlarged bronchial and intercostobronchial arterial
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Sedicles are disclosed (arrows).
o  the  positive  pressure  gradient  directed  from  the  feeding
rteries  to  the  lesion  center.  As  such,  the  afferent  feeding
rteries,  particularly  the  PAVM  accessory  feeders,  may  thus
e  overlooked  on  imaging  studies  (Fig.  16).
A  systemic  supply  has  been  reported  in  29%  of  70
re-embolization  work-up  PAVMs  patients1 (Fig.  15).  A  rela-
ionship  between  the  steal  phenomenon  (which  decreases
he  local  pulmonary  arterial  vascularization)  and  the  devel-
pment  of  a  systemic  supply  to  PAVMs  has  not  been
stablished  to  date.
1 Lacombe P et al., oral communication, 8th International Hered-
tary Hemorrhagic Telangiectasia Scientiﬁc Conference. Santander
pain 2009.
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Figure 16. Pulmonary arteriovenous malformation (PAVM) related steal phenomenon. Frontal Mini MIP CT scanner (a) shows a subpleural
peripheral low density area distal to a simple PAVM thought to correspond to the vascular steal phenomenon (arrow). Right common A7-A8
arterial trunk selective angiogram (b) shows the main feeding arteries of the simple PAVMs of A7 (arrowhead) and A8. The A8 feeding artery
looks very long owing to the reverse ﬂow related absence of collateral opaciﬁcation (arrow). The collateral reverse ﬂow upstream the
A7-A
H
T
a
t
m
[
f
P
p
g
t
t
p
n
t
F
tPAVM is favoured by the low-resistance high ﬂow. After successful 
reopaciﬁed, due to the steal phenomenon disappearance.
Treatment of pulmonary arteriovenous
malformation
PAVMs  should  be  treated  before  the  complication  may
appear,  owing  to  the  high  complication  rate  reaching  almost
50%,  and  even  more  during  pregnancy  [21].  In  diffuse  clinical
forms,  the  neurological  morbidity  (stroke  and  brain  abscess)
of  untreated  PAVMs  is  higher  and  reaches  70%  [20]. This
underlines  the  necessity  of  screening  PAVMs  by  using  non-
invasive  tests  in  HHT  families,  in  both  children  and  adults
[15].
It  is  recommended  that  patients  presenting  with  PAVMs
should  undergo  antibiotic  prophylaxis  prior  to  dental  and
surgical  interventions  to  reduce  paradoxical  embolic  abscess
risks  [6].
The  risk  of  cerebral  complications  is  usually  considered
signiﬁcant  when  the  feeding  artery  of  the  PAVM  exceeds
3  mm  in  diameter,  and  may  also  increase  in  patients  with
multiple  PAVMs  [35].  The  3  mm  cut-off  size  is  solely  based
on  empirical  data  regarding  patients  who  never  experi-
enced  such  cerebral  ischemic  events  below  that  size  [35,36].
a
t
i8 PAVMs embolization occlusion (c), A8 collateral ﬂow (arrows) is
owever,  Antibiotic  prophylaxis  remains  recommended  if
TCE  has  positive  ﬁndings,  even  if  CT  scanner  does  not  show
ny  image  suggestive  for  PAVM  [6].
Surgery  has  long  been  the  treatment  of  reference  until
he  seventies,  including  pneumonectomy,  lobectomy,  seg-
entectomy,  wedge  resection  or  vascular  ligation  (Fig.  7)
14]. Pulmonary  transplantation  has  been  performed  in  dif-
use  forms  associated  with  respiratory  insufﬁciency  [37].
ercutaneous  image-guided  embolotherapy  is  nowadays
referable  in  most  disease  cases  as  this  avoids  major  surgery,
eneral  anesthesia,  and  loss  of  pulmonary  parenchyma  func-
ion.  The  aim  of  transcatheter  embolization  is  to  occlude  all
he  PAVM  feeding  arteries  by  a  selective  catheterization  of
ulmonary  arteries  by  using  a  coaxial  system,  via  a  percuta-
eous  femoral  approach.  CT  scanner  is  the  key  examination
ool  for  the  planiﬁcation  of  percutaneous  embolization.
irstly,  CT  scanner  determines  the  number  and  location  of
he  PAVMs,  secondly  their  precise  angioarchitecture  char-
cteristics,  thirdly  the  presence  of  complications  (e.g.
hrombosis)  [34]. The  device  diameter  is  chosen  accord-
ng  to  the  measurement  data  of  the  afferent  feeding  artery
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iameter  on  both  CT  scanner  and  angiography  examinations.
e  stress  upon  the  necessity  to  perform  an  intravenous
ontrast  medium  injection  owing  to  the  potential  underes-
imation  of  catheterization  difﬁculties  on  unenhanced  CT
canner  examination.
Many  different  embolic  devices  are  now  available:
bered  steel  coils,  ﬁbered  platinium  coils  Nester,  ﬁbered
icrocoils,  hydrophilic  coils,  self  expandable  nitinol  plug.
etachable  balloons  are  no  longer  available  [38,39].The
nchor  technique  consists  of  coil  blockage  within  a  small
ollateral  branch  of  the  main  feeding  artery  immedi-
tely  upstream  the  PAVM,  allows  cross  sectional  optimal
cclusion  and  prevents  further  accidental  device  mobi-
ization  and  distal  migration  to  the  left  circulation
39]  (Figs.  2  and  17).  The  ﬁrst  positioned  coil  cre-
tes  a  scaffold  and  permits  the  blockage  of  other
evices.  By  packing  decreasing  diameter  devices  an  opti-
al  transsectional  occlusion  of  the  feeding  artery  can  be
chieved.
i
a
igure 17. Therapeutic anchor technique. The therapeutic anchor tec
ranch, closely upstream the pulmonary arteriovenous malformation (PA
lacement of other coils, lowering the risk of migration of embolization d
s performed by using complementary coils, of decreasing diameters. Co
he feeding artery (arrowhead). Success of percutaneous embolization 
ime.
igure 18. Successful transcatheter embolization. Axial CT scanner (a)
ormation (PAVM) of the apical segment of the right inferior lobe (arrow) 
xial CT scanner (b) shows coil occlusion of the afferent feeding artery aP.  Lacombe  et  al.
esults of pulmonary arteriovenous
alformation transcatheter embolization
nd  follow-up
uccessful  transcatheter  embolization  is  assessed  by  com-
lete  retraction  of  the  embolized  PAVM  (afferent  artery
ocated  downstream  the  coils/aneurismal  sac)  on  a  follow-
p  control  CT  scanner  (Figs.  18  and  19).  However,  TTCE  still
emains  positive  in  80—90%  of  successfully  treated  patients
40]. This  may  be  due  to  the  occult  presence  of  tiny  addi-
ional  PAVMs  that  were  not  detected  by  both  conventional
ngiography  and  CT  scanner  examinations  or  the  presence
f  a  tiny  PAVMs  feeding  artery  too  small  to  be  catheterized
40]. Transcatheter  embolization  of  PAVMs  is  eventually  efﬁ-
ient  and  durable  in  the  majority  of  patients  (83%  of  patients
n  Mager’s  study)  [41—43].
Immediate  complications  are  rare  in  experienced  hands
nd  include  device  migration,  gazeous  embolism,  stroke,
hnique consists of placing the ﬁrst coil into a small normal afferent
VM) (arrow). The ﬁrst coil creates a scaffold which facilitates the
evices through the PAVM. Progressive occlusion of the feeding artery
il packing is mandatory to achieve a complete lumen occlusion of
is assessed by the complete retraction of the aneurismal sac over
 shows a complex racemous sporadic pulmonary arteriovenous mal-
in a cyanotic 18-years-old female with clubbing. Post-embolization
nd subsequent complete retraction of the PAVM (arrow).
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Figure 19. Pulmonary arteriovenous malformation (PAVM) incomplete retraction at follow-up corresponding to secondary recanalization.
Work-up axial enhanced CT scanner (a) shows a simple peripheral PAVM in the anterior segment of the right lower lobe (arrow). Post-
embolization CT scanner one year after embolization (b) shows persistent or recurrent contrast enhancement of the partially retracted
PAVM (arrow). Central recanalization through the previously deposited coils was disclosed on angiography.
pulmonary  infarctions  and  hemoptysis  (Figs.  20  and  21).
Regarding  mid-  to  long-term  complications,  reperfusion  of
the  embolized  PAVM  may  be  due  to  the  following  mech-
anisms,  as  follows:  reperfusion  through  or  around  the
anchored  coils  (Figs.  22  and  23);  development  of  pul-
monary  to  PAVM  neovasculature  anastomoses  (Fig.  23),
reperfusion  by  systemic  bronchial  and/or  non  bronchial
arteries  (Fig.  24)  [41—43].  In  case  of  systemic  bronchial
artery  supply,  post-embolization  systemic  supply  may  be
responsible  for  delayed  hemoptysis.
CT  scanner  follow-up  examination  may  highlight  abnor-
mal  secondary  PAVM  reperfusion  —  indirectly  by  showing
Figure 20. Acute pulmonary ischemia after percutaneous pul-
monary arteriovenous malformation embolization. Axial CT scanner
shows multiple areas of pleural base pulmonary infarction and left
pleural effusion 10 days after bilateral embolization (arrows).
incomplete  PAVM  retraction  —  and  directly  by  using  I.V.
contrast  iodinated  medium  injection  [44,45]. CT  scanner
imaging  follow-up  is  mandatory  every  year  in  subsegmental
diffuse  PAVMs  types,  and  every  ﬁve  years  in  the  other  cases,
owing  to  the  risk  of  late  PAVM  recanalization  and  regrowth
of  untreated  PAVMs  [5,41—43].
Figure 21. Post-embolization pulmonary arteriovenous malfor-
mation (PAVM) thrombosis. This 36-years-old man presenting with
multiple PAVMs and liver involvement with hepatic artery enlarge-
ment (11 mm). Enhanced CT scanner was performed at stroke onset
(hemiplegia) seven hours after PAVMs embolization. The feeding
artery was completely occluded but a clot is shown within the
aneurismal sac extending downstream reaching the draining vein
(arrow). The enhancement of the aneurismal sac comes from a ret-
rograde ﬁlling of the pulmonary vein related to the high cardiac
output secondary to the liver involvement. On cerebral MR imag-
ing, a non obstructive clot was detected within the middle cerebral
artery, without cerebral infarction. Anticoagulant therapy was ini-
tiated and patient had an immediate full clinicaly recovery. In our
practice, anticoagulation is initiated after PAVM embolization as
soon as a retrograde ﬁlling of the embolized PAVM is depicted on
control angiography.
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Figure 22. Recanalization around the previously deposited coils two years after pulmonary arteriovenous malformation (PAVM) emboliza-
tion. Imaging work-up before re treatment. Enhanced oblique MIP CT scanner (a) shows recanalization of a previously treated right laterobasal
PAVM. A recurrent ﬂow through previously deposited coils is present. Th
coils. Selective angiography (b) shows reopening channels around the anchored coils (arrow).
Figure 23. Pulmonary arteriovenous malformation (PAVM)
recanalization through the anchored coils and pulmonary-to-PAVM
anastomoses. Angiogram shows the recanalization of the affer-
ent feeding artery (left A10) throughout previously thrombosed
a
n
enchored coils (arrow) and the development of pulmonary-to-PAVM
eovasculature anastomoses (large arrow). Both mechanisms
xplain the opaciﬁcation of the draining vein (arrowhead).e feeding artery of the PAVM is shown patent immediately beyond
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Figure 24. Reperfusion of pulmonary arteriovenous malformation (PAVM) due to post-embolization systemic neovasculature development.
High cardiac output failure in a 33-years-old female presenting with diffuse subsegmental form of PAVMs throughout both lungs ﬁve years
after serial peripheral-to-proximal percutaneous embolization. Axial enhanced CT scanner (a) shows huge enlargement of systemic bronchial
(arrow), intercostal and internal thoracic arteries (large arrow), and concomitant reperfusion of a left anterior PAVM (arrowhead). Axial
enhanced CT scanner examination (b) shows huge enlargement of both inferior phrenic arteries (arrows) with retrograde ﬁlling of multiple
 over
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[peripheral embolized PAVMs (arrowheads). This reperfusion can be
arteries via systemic supplies (false negative angiograms).
Conclusion
PAVMs  are  one  of  the  main  causes  of  morbidity  in  patients
presenting  with  HHT  disease,  owing  to  the  risks  of  rupture
as  well  as  paradoxical  embolism  exposing  to  stroke  and/or
cerebral  abscess.  PAVMs  should  be  carefully  screened  in
the  patient  and  own  family  by  using  transthoracic  contrast
echocardiography  and  CT  scanner  examination.  Percuta-
neous  embolization  has  become  the  treatment  of  choice  of
PAVM,  due  to  its  safety  and  efﬁciency  in  experienced  hands.
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